(Q46617736)
Statements
1 reference
A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens (English)
1 reference
1 reference
Patrick Schoffski
1 reference
Jaap Verweij
1 reference
Isabelle Ray-Coquard
1 reference
Sandrine Marreaud
1 reference
Martine van Glabbeke
1 reference
Jeremy S Whelan
1 reference
Binh N Bui
1 reference
1 April 2008
1 reference
1 reference
13
1 reference
4
1 reference
467-473
1 reference
Identifiers
1 reference
1 reference